Newspaper Publication Regarding EGM of Vivimed Labs Limited
Vivimed Labs Limited has published a newspaper advertisement regarding the Extraordinary General Meeting (EGM) of the Company.
This is a standard compliance announcement and has a low impact on the company's operations or stock price.
The announcement is a routine disclosure regarding the publication of a notice for an Extraordinary General Meeting.
* Vivimed Labs Limited has published a newspaper advertisement regarding the Extraordinary General Meeting (EGM) of the Company. * The EGM will be held through Video Conferencing. * The dispatch of Notice through electronic mode occurred on November 17, 2025, as per circulars issued by the Regulatory Authorities. * The advertisement appeared in the Financial Express (English) and Hosadigantha (Kannada) on November 20, 2025. * The same is also available on the Company's website at www.vivimelabs.com.
What to do with a filing like this
Vivimed Labs Limited filed this with the NSE as a statutory disclosure, categorised under shareholder meetings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vivimed Labs Limited. Read the original for the full detail.